These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 2850215
1. A tumor necrosis factor binding protein is present in human biological fluids. Peetre C, Thysell H, Grubb A, Olsson I. Eur J Haematol; 1988 Nov; 41(5):414-9. PubMed ID: 2850215 [Abstract] [Full Text] [Related]
2. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. Lantz M, Gullberg U, Nilsson E, Olsson I. J Clin Invest; 1990 Nov; 86(5):1396-1402. PubMed ID: 2173717 [Abstract] [Full Text] [Related]
3. Isolation and characterization of a tumor necrosis factor binding protein from urine. Olsson I, Lantz M, Nilsson E, Peetre C, Thysell H, Grubb A, Adolf G. Eur J Haematol; 1989 Mar; 42(3):270-5. PubMed ID: 2924890 [Abstract] [Full Text] [Related]
4. A 63 kDa tumor necrosis factor inhibitor released from a human monocytic leukemia cell line, THP-1. Aso H, Yoshite O, Tomioka Y, Rose MT, Mizugaki M. Microbiol Immunol; 1999 Mar; 43(1):53-9. PubMed ID: 10100747 [Abstract] [Full Text] [Related]
5. Efficient purification of recombinant human tumor necrosis factor beta from Escherichia coli yields biologically active protein with a trimeric structure that binds to both tumor necrosis factor receptors. Schoenfeld HJ, Poeschl B, Frey JR, Loetscher H, Hunziker W, Lustig A, Zulauf M. J Biol Chem; 1991 Feb 25; 266(6):3863-9. PubMed ID: 1847389 [Abstract] [Full Text] [Related]
6. Solubilization of human placental tumor necrosis factor receptors as a complex with a guanine nucleotide-binding protein. Hayakawa M, Hori T, Shibamoto S, Tsujimoto M, Oku N, Ito F. Arch Biochem Biophys; 1991 May 01; 286(2):323-9. PubMed ID: 1654785 [Abstract] [Full Text] [Related]
7. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. Engelmann H, Aderka D, Rubinstein M, Rotman D, Wallach D. J Biol Chem; 1989 Jul 15; 264(20):11974-80. PubMed ID: 2545693 [Abstract] [Full Text] [Related]
8. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma. Andrews JS, Berger AE, Ware CF. J Immunol; 1990 Apr 01; 144(7):2582-91. PubMed ID: 1969453 [Abstract] [Full Text] [Related]
9. TNF inhibitor with a low molecular weight found in the human sera. Shimoda A, Hanaumi K, Kumagai K. Tohoku J Exp Med; 1995 Dec 01; 177(4):327-35. PubMed ID: 8928192 [Abstract] [Full Text] [Related]
10. Tumor necrosis factor-alpha, but not lymphotoxin, stimulates growth of tumor cells in hairy cell leukemia. Buck C, Digel W, Schöniger W, Stefanic M, Ragnavachar A, Heimpel H, Porzsolt F. Leukemia; 1990 Jun 01; 4(6):431-4. PubMed ID: 2162999 [Abstract] [Full Text] [Related]
11. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity. Loetscher H, Gentz R, Zulauf M, Lustig A, Tabuchi H, Schlaeger EJ, Brockhaus M, Gallati H, Manneberg M, Lesslauer W. J Biol Chem; 1991 Sep 25; 266(27):18324-9. PubMed ID: 1655744 [Abstract] [Full Text] [Related]
12. Synergistic growth-inhibitory activity of tumour necrosis factor and alpha interferon. Contribution to the monocyte-derived cytostatic activity towards human leukaemia K562 cells. Nissen-Meyer J, Austgulen R, Espevik T. Scand J Immunol; 1988 Nov 25; 28(5):627-37. PubMed ID: 3212388 [Abstract] [Full Text] [Related]
13. Binding and crosslinking of 125I-labeled recombinant human tumor necrosis factor to cell surface receptors. Yoshie O, Tada K, Ishida N. J Biochem; 1986 Sep 25; 100(3):531-41. PubMed ID: 3023310 [Abstract] [Full Text] [Related]
14. Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation. Pennica D, Kohr WJ, Fendly BM, Shire SJ, Raab HE, Borchardt PE, Lewis M, Goeddel DV. Biochemistry; 1992 Feb 04; 31(4):1134-41. PubMed ID: 1310420 [Abstract] [Full Text] [Related]
15. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. Engelmann H, Novick D, Wallach D. J Biol Chem; 1990 Jan 25; 265(3):1531-6. PubMed ID: 2153136 [Abstract] [Full Text] [Related]
16. Identification of a new receptor subtype for tumor necrosis factor-alpha. Schwalb DM, Han HM, Marino M, Warren R, Porter A, Goh C, Fair WR, Donner DB. J Biol Chem; 1993 May 15; 268(14):9949-52. PubMed ID: 7683686 [Abstract] [Full Text] [Related]
17. Species specificity of human and murine tumor necrosis factor. A comparative study of tumor necrosis factor receptors. Smith RA, Kirstein M, Fiers W, Baglioni C. J Biol Chem; 1986 Nov 15; 261(32):14871-4. PubMed ID: 3021754 [Abstract] [Full Text] [Related]
18. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor. Seckinger P, Isaaz S, Dayer JM. J Biol Chem; 1989 Jul 15; 264(20):11966-73. PubMed ID: 2545692 [Abstract] [Full Text] [Related]
19. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. Lantz M, Thysell H, Nilsson E, Olsson I. J Clin Invest; 1991 Dec 15; 88(6):2026-31. PubMed ID: 1752960 [Abstract] [Full Text] [Related]
20. Purification of type I and type II tumor necrosis factor receptors from human lung tissue. Abdolrasulnia R, Shepherd VL. Am J Respir Cell Mol Biol; 1992 Jul 15; 7(1):42-8. PubMed ID: 1320902 [Abstract] [Full Text] [Related] Page: [Next] [New Search]